Evaluation of MyoStrain™ in Clinical Practice

University of Kansas

Status: Completed

Conditions: Sarcoidosis; Coronary Artery Disease; Cardiac Failure; Myocarditis; Lupus; Amyloidosis; Drug Toxicity

Treatments: Procedure: Diagnostic Test: Myostrain

Study type: Observational

Funder types: Other

Identifiers

NCT03825224

STUDY00142902

Details and patient eligibility

About

Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice

Full description

Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice to determine how the use may alter treatment decisions and clinical outcomes in patients who are undergoing cardiac MRI.

Enrollment: 19 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients already scheduled for diagnostic testing with commercially available imaging modality (cardiac MRI)
• The patient population will include (but not limited to), those being evaluated for heart disease and heart failure that may be related to vascular disease (coronary artery disease), drug related heart failure (chemotherapy, alcohol), inflammatory systemic conditions (sarcoidosis, amyloidosis, lupus), myocarditis, and/or infectious etiologies
• Provided written informed consent

Exclusion criteria

• Contraindication to Magnetic Resonance Imaging

Trial design